Greenlight Biosciences Holdings Stock Revenue
Greenlight Biosciences Holdings fundamentals help investors to digest information that contributes to Greenlight Biosciences' financial success or failures. It also enables traders to predict the movement of Greenlight Stock. The fundamental analysis module provides a way to measure Greenlight Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenlight Biosciences stock.
Greenlight |
Greenlight Biosciences Holdings Company Revenue Analysis
Greenlight Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Greenlight Biosciences Revenue | 6.38 M |
Most of Greenlight Biosciences' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenlight Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Greenlight Biosciences Holdings reported 6.38 M of revenue. This is 99.92% lower than that of the Biotechnology sector and 99.14% lower than that of the Health Care industry. The revenue for all United States stocks is 99.93% higher than that of the company.
Greenlight Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenlight Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Greenlight Biosciences could also be used in its relative valuation, which is a method of valuing Greenlight Biosciences by comparing valuation metrics of similar companies.Greenlight Biosciences is currently under evaluation in revenue category among its peers.
Greenlight Fundamentals
| Return On Equity | -3.67 | |||
| Return On Asset | -0.82 | |||
| Operating Margin | (14.94) % | |||
| Current Valuation | 90.5 M | |||
| Shares Outstanding | 151.68 M | |||
| Shares Owned By Insiders | 42.90 % | |||
| Shares Owned By Institutions | 26.85 % | |||
| Number Of Shares Shorted | 1.03 M | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 41.41 X | |||
| Revenue | 6.38 M | |||
| Gross Profit | (87.22 M) | |||
| EBITDA | (153.99 M) | |||
| Net Income | (167.06 M) | |||
| Cash And Equivalents | 44.13 M | |||
| Cash Per Share | 0.36 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 2.30 % | |||
| Current Ratio | 1.16 X | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (1.12) X | |||
| Target Price | 0.6 | |||
| Number Of Employees | 10 | |||
| Beta | 1.44 | |||
| Market Capitalization | 45.43 M | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
| Working Capital | 35.75 M | |||
| Z Score | -6.71 | |||
| Net Asset | 148.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |